Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Calendar of Events
    • Presentations
  • Financial Info
    • SEC Filings
    • Supplemental Financial Information
  • Corporate Governance
    • Documents & Charters
    • Leadership
    • Board of Directors
    • Committee Composition
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Investor Resources
    • FAQ
    • Information Requests
    • IR Contact

Lantheus Announces Sale of SPECT Business to SHINE Technologies

  • Read more about Lantheus Announces Sale of SPECT Business to SHINE Technologies

Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

  • Read more about Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies

Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

  • Read more about Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time

Lantheus Completes Acquisition of Evergreen Theragnostics

  • Read more about Lantheus Completes Acquisition of Evergreen Theragnostics

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

  • Read more about Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

Lantheus to Present at Upcoming Investor Conferences

  • Read more about Lantheus to Present at Upcoming Investor Conferences

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

  • Read more about Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

  • Read more about Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

Dr. Phuong Khanh (PK) Morrow

  • Member of the Science & Technology Committee
  • Member of the Talent & Compensation Committee
Dr. Phuong Khanh (PK) Morrow

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

  • Read more about Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Site - Shareholder Services

Print Page
RSS Feeds
Email Alerts
  • Copyright © 2025 Lantheus Holdings, Inc. All rights reserved.